FedEx Corporation vs Kymera Therapeutics Inc. Common Stock — how do they compare? FedEx Corporation trades at $291.98 (market cap $68.77B), while Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B). The key difference: FedEx Corporation is far larger — about 7.8× Kymera Therapeutics Inc. Common Stock's market cap, and FedEx Corporation pays a 1.68% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold FedEx Corporation for 87 Days and Kymera Therapeutics Inc. Common Stock for 0 Days on average.
| FDX | KYMR | |
|---|---|---|
Market Cap | $68.77B | $8.87B |
Volume | 914,308 | 779,107 |
Sector | Industrials | Health |
52-Week High | $339.35 | $127.31 |
52-Week Low | $189.87 | $55.80 |
Typical Hold Time | 87 Days | 0 Days |
Enterprise Value | $98.41B | $8.26B |
Dividend Yield | 1.68% | — |
Signals from Pluang's Aura AI — not financial advice
FedEx (FDX) trades at $291.28, down 0.33% on the day, with a bearish technical signal. The stock shows solid fundamentals with a P/E of 15.67 and net income margin of 4.68%, though revenue has been flat recently. Recent news includes a $300 million electric truck order and shareholder approval of executive pay. Cash flow is projected to improve significantly in 2026.
The outlook is mixed: strong analyst buy consensus (57%) and a $307.55 price target suggest upside, but technical indicators and rising fuel costs pose near-term risks. Long-term growth depends on execution of cost cuts and capitalizing on industry tailwinds.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
FedEx pioneered overnight delivery in 1973 and remains the world's largest express package provider. In its fiscal 2020 (ended May 2020), FedEx derived 51% of revenue from its express division, 33% from ground, and 10% from freight, its asset-based less-than-truckload shipping segment. The remainder comes from other services, including FedEx Office, which provides document production/shipping, and FedEx Logistics, which provides global forwarding. FedEx acquired Dutch parcel delivery firm TNT Express in 2016. TNT was previously the fourth-largest global parcel delivery provider.
Read more on FDX →Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →